Category Press Releases

Clinical Data from DAFFODIL™ Study on DAYBUE® (trofinetide) in Rett Syndrome Published

Clinical Data from DAFFODIL™ Study on DAYBUE® (trofinetide) in Rett Syndrome Published

DAFFODIL™ Study Results Highlight Long-Term Safety and Efficacy of DAYBUE® (Trofinetide) in Younger Patients with Rett Syndrome Acadia Pharmaceuticals Inc. has announced the publication of results from the open-label DAFFODIL™ study in the journal Med. The study evaluated the long-term…

Read MoreClinical Data from DAFFODIL™ Study on DAYBUE® (trofinetide) in Rett Syndrome Published
Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices

Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices

Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices Repligen Corporation, a leader in bioprocessing technology, has announced the acquisition of 908 Devices Inc.’s desktop portfolio for process analytical technology (PAT) applications. This…

Read MoreRepligen Acquires Bioprocessing Analytics Portfolio from 908 Devices